Enzastaurin - CISMeF

Preferred Label : Enzastaurin;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. Enzastaurin blocks certain cell signaling pathways, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of serine threonine kinase inhibitor and a type of antiangiogenesis agent.;

UNII : UC96G28EQF;

InChIKey : AXRCEOKUDYDWLF-UHFFFAOYSA-N;

CAS number : 170364-57-5;

Chemical formula : C32H29N5O2;

Codes from synonyms : CDR0000390276;

Details

Origin ID

C77392;

UMLS CUI

C1327830;

Currated CISMeF NLP mapping
- enzastaurin [MeSH concept]
- enzastaurin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- enzastaurin [MeSH Supplementary Concept]
- enzastaurin [MeSH concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
has_salt_form
- Enzastaurin Hydrochloride [NCIt concept]
has_target
- Protein Kinase C [NCIt concept]
is_free_acid_or_base_form_of
- Enzastaurin Hydrochloride [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients